Regulation of alloreactivity in the popliteal lymph node assay by the new immunosuppressants: Malononitrilamides

Transplant International

Volumn 11, Issue SUPPL. 1, 1998, Pages

  Schorlemmer, H U ^a   Ruuth, E ^a   Kurrle, R ^a  

^a SANOFI   (France)

Author keywords

Alloreactivity; Immunosuppression; Local graft versus host reaction; Malononitrilamides; Popliteal lymph node assay

Indexed keywords

2 CYANO 3 HYDROXY N (4 (TRIFLUOROMETHYL)PHENYL) 2 HEPTEN 6 YNAMIDE; 2-CYANO-3-HYDROXY-N-(4-(TRIFLUOROMETHYL)PHENYL)-2-HEPTEN-6-YNAMIDE; ALKYNE; IMMUNOSUPPRESSIVE AGENT; ISOXAZOLE DERIVATIVE; NITRILE; X 910279;

ANIMAL; ARTICLE; BROWN NORWAY RAT; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LEWIS RAT; LYMPH NODE; RAT;

ALKYNES; ANIMALS; GRAFT VS HOST DISEASE; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; LYMPH NODES; NITRILES; RATS; RATS, INBRED BN; RATS, INBRED LEW;

EID: 0031609664     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1998.tb01178.x     Document Type: Article

References (11)

1. Ford WL, Burr W, Simonsen G (1970) A lymph node weight assay for the graft-versus-host activity of rat lymphoid cells. Transplantation 10: 258-266
2. Kurrle R, Bartlett RR, Ruuth E, Lauffer L, Schorlemmer HU (1996) Malononitrilamides inhibit T- and B-cell responsiveness. Transplant Proc 28: 3053-3056
3. Kurrle R, Ruuth E, Bartlett RR, Lauffer L, Schorlemmer HU (1997) Malononitrilamides inhibit T- and B-cell responsiveness in different species. Transplant Proc 29: 1302-1303
4. Lin Y, Segers C, Waer M (1996) Efficacy of the malononitrilamide X 920715 as compared with leflunomide in cardiac allo- and xenotransplantation in rats. Transplant Proc 28: 3036
5. Morris RE, Huang X, Cao W, Zheng B, Shorthouse RA (1995) Leflunomide (HWA 486) and its analog suppress T-and B-cell proliferation in vitro, acute rejection, ongoing rejection, and anti-donor antibody synthesis in mouse, rat, and cynomolgus monkey transplant recipients as well as arterial intimal thickening after balloon catheter injury. Transplant Proc 27: 445-447
6. Schorlemmer HU, Bartlett RR (1997) Malononitrilamides (MNA 279 and MNA 715) have therapeutic activity in acute and chronic relapsing experimental allergic encephalomyelitis (EAE). Inflamm Res 46: S163-S164
7. Schorlemmer HU, Kurrle R (1996) Control of mouse-to-rat skin xenograft rejection by malononitrilamides. Transplant Proc 28: 3037-3030
8. Schorlemmer HU, Brendel S, Bartlett RR (1996) Malononitrilamides prevent the development of murine systemic lupus erythematosus-like diseases in BDF1 hybrid mice and MRL/lpr autoimmune mice. Transplant Proc 28: 3040-3042
9. Schorlemmer HU, Schwab W, Ruuth E, Kurrle R (1996) Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides. Transplant Proc 28: 3048-3050
10. Schorlemmer HU, Bartlett RR, Kurrle R (1997) Analogues of leflunomide's primary metabolite, the malononitrilamides, prevent the development of graft-versus-host disease. Transplant Proc 29: 1298-1301
11. Williamson RA, Yea CM, Robson PA, Curnock AP, Gadher S, Hambleton AB, Woodward K, Bruneau JM, Hambleton P, Moss D, Thomson TA, Spinella-Jaegle S, Morand P, Courtin D, Sautes C, Westwood R, Hercend T, Kuo EA, Ruuth E (1995) Dihydroorotate dehydrogenase is a high affinity binding protein for A 771726 and mediator of a range of biological effects of the immunomodulatory compound. J Biol Chem 270: 22467-22472